QNCX - Quince Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Quince Therapeutics, Inc.
IPO Date: May 8, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $29.98M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.13 | 5.44%
Avg Daily Range (30 D): $1.18 | 3.75%
Avg Daily Range (90 D): $0.64 | 3.65%
Institutional Daily Volume
Avg Daily Volume: 6.45M
Avg Daily Volume (30 D): .02M
Avg Daily Volume (90 D): .5M
Trade Size
Avg Trade Size (Sh.): 916
Avg Trade Size (Sh.) (30 D): 28
Avg Trade Size (Sh.) (90 D): 208
Institutional Trades
Total Institutional Trades: 0
Avg Institutional Trade: $M
Avg Institutional Trade (30 D): $M
Avg Institutional Trade (90 D): $M
Avg Institutional Trade Volume: M
Avg Institutional Trades (Per Day): 0
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
May 18, 2026 @ 1:26 PM
Quince Announces Acquisition of Orphai and up to $...
Source: Not Specified
Mar 8, 2024 @ 9:40 AM
The Zacks Analyst Blog Highlights Quince Therapeut...
Source: Zacks Equity Research
Mar 7, 2024 @ 9:47 PM
Don't Know Much Biology? Tips for Picking Microcap...
Source: Mark Zinski
Dec 8, 2023 @ 1:50 PM
SHF Holdings And 3 Other Stocks Under $2 Insiders ...
Source: Avi Kapoor
Dec 4, 2023 @ 2:12 PM
Over $2M Bet On This Industrial Stock? Check Out T...
Source: Lisa Levin
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-13.02 $-12.31 $3.6
Diluted EPS $-13.02 $-12.31 $2.88
Revenue $M $M $M
Gross Profit
Net Income / Loss $-94.64M $-75.41M $30.57M
Operating Income / Loss $-127.16M $-79.78M $-14.59M
Cost of Revenue
Net Cash Flow $99.16M $97.82M $12.35M
PE Ratio    
Splits
Jun 30, 2026 1:20
Apr 13, 2026 1:10